Authors: Wells, G Anderson, J Beaton, D Bellamy, N Boers, M Bombardier, C Breedveld, F Carr, A Cranney, A Dougados, M Felson, D Kirwan, J Schiff, M Shea, B Simon, L Smolen, J Strand, V Tugwell, P van Riel, P Welch, VA

Citation: G. Wells et al., Minimal clinically important difference module: Summary, recommendations, and research agenda, J RHEUMATOL, 28(2), 2001, pp. 452-454

Authors: Silman, A Klareskog, L Breedveld, F Bresnihan, B Maini, R van Riel, P Symmons, D

Citation: A. Silman et al., Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds, ANN RHEUM D, 59(6), 2000, pp. 419-420

Authors: Bresnihan, B van Riel, P

Citation: B. Bresnihan et P. Van Riel, Established rheumatoid arthritis - Preface, BEST PR R C, 13(4), 1999, pp. VII-VII

Authors: Wolfe, F Lassere, M van der Heijde, D Stucki, G Suarez-Almazor, M Pincus, T Eberhardt, K Kvien, TK Symmons, D Silman, A van Riel, P Tugwell, P Boers, M

Citation: F. Wolfe et al., Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology, J RHEUMATOL, 26(2), 1999, pp. 484-489